Perspective Therapeutics (CATX) Operating Leases (2019 - 2026)

Perspective Therapeutics (CATX) has 8 years of Operating Leases data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 32.2% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 32.2% YoY), and the FY2025 full-year result was $1.0 million, down 29.62% from the prior year.
• Operating Leases advanced to $1.6 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.7 million in Q3 2024 to a low of $186000.0 in Q3 2022.
• A 5-year average of $975500.0 and a median of $1.0 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases sank 61.34% in 2022 and soared 743.55% in 2023, its largest moves.
• Tracing CATX's Operating Leases over 5 years: stood at $186000.0 in 2022, then jumped by 319.35% to $780000.0 in 2023, then jumped by 83.08% to $1.4 million in 2024, then slipped by 29.62% to $1.0 million in 2025, then surged by 54.43% to $1.6 million in 2026.
• Business Quant data shows CATX's Operating Leases at $1.6 million in Q1 2026, $1.0 million in Q4 2025, and $971000.0 in Q3 2025.